Table 1 Clinical and pathological features of the patient groups according to Fisher’s test
Recurrence | Absent | Present | Total | p value | |
|---|---|---|---|---|---|
Selected variables before pairing | |||||
CS-TNM | EC I | 9 (69%) | 4 (31%) | 13 | 0.385 |
EC II | 13 (56%) | 10 (43%) | 23 | ||
EC III | 13 (46%) | 15 (54%) | 28 | ||
CS-T (TNM) | T1 | 15 (56%) | 12 (44%) | 27 | 0.742 |
T2 | 10 (56%) | 8 (44%) | 18 | ||
T3 | 6 (67%) | 3 (33%) | 9 | ||
T4 | 4 (40%) | 6 (60%) | 10 | ||
CS-N (TNM) | N0 | 17 (68%) | 8 (32%) | 25 | 0.378 |
N1 | 9 (47%) | 10 (53%) | 19 | ||
N2 | 5 (50%) | 5 (50%) | 10 | ||
N3 | 4 (40%) | 6 (60%) | 10 | ||
Categorical variables observed after pairing | |||||
Histology | Ductal | 30 (61%) | 19 (39%) | 49 | 0.078 |
Lobular | 5 (33%) | 10 (67%) | 15 | ||
ER | ER + | 21 (62%) | 13 (38%) | 34 | 0.226 |
ER - | 14 (47%) | 16 (53%) | 30 | ||
PR | PR + | 16 (76%) | 5 (24%) | 21 | 0.018 |
PR - | 19 (44%) | 24 (56%) | 43 | ||
Her2 | Her2 + | 5 (38%) | 8 (62%) | 13 | 0.158 |
Her2 - | 30 (59%) | 21 (41%) | 51 | ||
Molecular | Luminal | 23 (64%) | 13 (36%) | 36 | 0.265 |
Subtypes | Basal like | 9 (45%) | 11 (55%) | 20 | |
Her2 | 3 (38%) | 5 (62%) | 8 | ||